Primary cutaneous marginal zone lymphoma treated with doxycycline in a pediatric patient | Zendy

Jothishankar Balaji | Zendy; Di Raimondo Cosimo | Zendy; Mueller Lisa | Zendy; Zain Jasmine | Zendy; Parekh Vishwas | Zendy; Abdulla Farah | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Primary cutaneous marginal zone lymphoma treated with doxycycline in a pediatric patient

Author(s) -

Jothishankar Balaji,

Di Raimondo Cosimo,

Mueller Lisa,

Zain Jasmine,

Parekh Vishwas,

Abdulla Farah

Publication year - 2020

Publication title -

pediatric dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.542

H-Index - 73

eISSN - 1525-1470

pISSN - 0736-8046

DOI - 10.1111/pde.14165

Subject(s) - doxycycline , medicine , asymptomatic , dermatology , borrelia burgdorferi , lymphoma , biopsy , surgery , pathology , immunology , antibiotics , antibody , microbiology and biotechnology , biology

We present the third reported case of a primary cutaneous marginal zone lymphoma (PCMZL) treated with doxycycline in a pediatric patient with negative serology for Borrelia burgdorferi . A 14‐year‐old boy presented with multiple asymptomatic erythematous papules and nodules on his extremities and trunk which biopsy confirmed to be PCMZL. He was started on doxycycline and experienced a near‐complete response. Given the favorable side effect profile of doxycycline and the indolent nature of PCMZL, we believe doxycycline is a possible therapy for PCMZL pediatric patients who have widely disseminated cutaneous disease.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research